RecruitingNCT02551081

Genomic Sequencing and Personalized Treatment for Birth Defects in Neonatal Intensive Care Units


Sponsor

Children's Hospital of Fudan University

Enrollment

2,000 participants

Start Date

Oct 1, 2015

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of study is to evaluate the benefits of using the Next Generation Sequencing Technology to diagnose birth defects and genetic diseases. The results from genomic sequencing can also significantly shorten the time of examination, improve the diagnosis rate, guide the clinical treatments. So the ultimate goal is individualized or personalized therapy and promote prognosis.


Eligibility

Max Age: 28 Days

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with congenital malformation, genetic disease, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include up to age 28 Days.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Children Hospital of Fudan University

Shanghai, Shanghai Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02551081


Related Trials